vs
Side-by-side financial comparison of Porch Group, Inc. (PRCH) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $92.9M, roughly 1.3× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs -3.9%, a 28.9% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 23.3%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 26.4%).
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
PRCH vs VCEL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $121.1M | $92.9M |
| Net Profit | $-4.7M | $23.2M |
| Gross Margin | 52.7% | 78.7% |
| Operating Margin | 34.7% | 24.1% |
| Net Margin | -3.9% | 25.0% |
| Revenue YoY | 100.0% | 23.3% |
| Net Profit YoY | 2.0% | 17.3% |
| EPS (diluted) | $-0.04 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $121.1M | — | ||
| Q4 25 | $112.3M | $92.9M | ||
| Q3 25 | $115.1M | $67.5M | ||
| Q2 25 | $107.0M | $63.2M | ||
| Q1 25 | $84.5M | $52.6M | ||
| Q4 24 | $75.3M | $75.4M | ||
| Q3 24 | $77.7M | $57.9M | ||
| Q2 24 | $75.9M | $52.7M |
| Q1 26 | $-4.7M | — | ||
| Q4 25 | $-3.5M | $23.2M | ||
| Q3 25 | $-10.9M | $5.1M | ||
| Q2 25 | $2.6M | $-553.0K | ||
| Q1 25 | $8.4M | $-11.2M | ||
| Q4 24 | $30.5M | $19.8M | ||
| Q3 24 | $14.4M | $-901.0K | ||
| Q2 24 | $-64.3M | $-4.7M |
| Q1 26 | 52.7% | — | ||
| Q4 25 | 99.5% | 78.7% | ||
| Q3 25 | 75.6% | 73.5% | ||
| Q2 25 | 70.9% | 73.7% | ||
| Q1 25 | 77.4% | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | 79.4% | 71.9% | ||
| Q2 24 | 22.1% | 69.5% |
| Q1 26 | 34.7% | — | ||
| Q4 25 | 14.7% | 24.1% | ||
| Q3 25 | 14.2% | 5.1% | ||
| Q2 25 | 4.7% | -3.2% | ||
| Q1 25 | -1.5% | -24.3% | ||
| Q4 24 | 33.3% | 24.5% | ||
| Q3 24 | -3.2% | -4.3% | ||
| Q2 24 | -69.2% | -11.5% |
| Q1 26 | -3.9% | — | ||
| Q4 25 | -3.1% | 25.0% | ||
| Q3 25 | -9.4% | 7.5% | ||
| Q2 25 | 2.4% | -0.9% | ||
| Q1 25 | 9.9% | -21.4% | ||
| Q4 24 | 40.5% | 26.3% | ||
| Q3 24 | 18.5% | -1.6% | ||
| Q2 24 | -84.8% | -8.9% |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $0.00 | $0.46 | ||
| Q3 25 | $-0.10 | $0.10 | ||
| Q2 25 | $0.00 | $-0.01 | ||
| Q1 25 | $0.07 | $-0.23 | ||
| Q4 24 | $0.34 | $0.40 | ||
| Q3 24 | $0.12 | $-0.02 | ||
| Q2 24 | $-0.65 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $68.4M | $137.5M |
| Total DebtLower is stronger | $391.3M | — |
| Stockholders' EquityBook value | $26.3M | $354.6M |
| Total Assets | $806.6M | $488.0M |
| Debt / EquityLower = less leverage | 14.87× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $68.4M | — | ||
| Q4 25 | $57.3M | $137.5M | ||
| Q3 25 | $85.0M | $135.4M | ||
| Q2 25 | $79.8M | $116.9M | ||
| Q1 25 | $70.4M | $112.9M | ||
| Q4 24 | $191.7M | $116.2M | ||
| Q3 24 | $238.6M | $101.7M | ||
| Q2 24 | $308.4M | $102.5M |
| Q1 26 | $391.3M | — | ||
| Q4 25 | $392.8M | — | ||
| Q3 25 | $387.1M | — | ||
| Q2 25 | $394.1M | — | ||
| Q1 25 | $409.2M | — | ||
| Q4 24 | $403.9M | — | ||
| Q3 24 | $399.0M | — | ||
| Q2 24 | $436.8M | — |
| Q1 26 | $26.3M | — | ||
| Q4 25 | $-24.6M | $354.6M | ||
| Q3 25 | $-27.9M | $321.9M | ||
| Q2 25 | $-29.3M | $306.8M | ||
| Q1 25 | $-52.4M | $295.5M | ||
| Q4 24 | $-43.2M | $292.0M | ||
| Q3 24 | $-77.0M | $257.5M | ||
| Q2 24 | $-101.9M | $243.0M |
| Q1 26 | $806.6M | — | ||
| Q4 25 | $797.4M | $488.0M | ||
| Q3 25 | $787.7M | $453.3M | ||
| Q2 25 | $770.7M | $435.6M | ||
| Q1 25 | $802.3M | $424.6M | ||
| Q4 24 | $814.0M | $432.7M | ||
| Q3 24 | $867.3M | $390.4M | ||
| Q2 24 | $876.1M | $376.8M |
| Q1 26 | 14.87× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.2M | $15.0M | ||
| Q3 25 | $40.8M | $22.1M | ||
| Q2 25 | $35.6M | $8.2M | ||
| Q1 25 | $-11.2M | $6.6M | ||
| Q4 24 | $-26.6M | $22.2M | ||
| Q3 24 | $12.4M | $10.2M | ||
| Q2 24 | $-26.0M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1M | $12.8M | ||
| Q3 25 | $40.7M | $19.5M | ||
| Q2 25 | $35.4M | $81.0K | ||
| Q1 25 | $-11.2M | $-7.6M | ||
| Q4 24 | $-26.8M | $8.5M | ||
| Q3 24 | $12.2M | $-9.2M | ||
| Q2 24 | $-26.0M | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | 13.8% | ||
| Q3 25 | 35.4% | 28.8% | ||
| Q2 25 | 33.0% | 0.1% | ||
| Q1 25 | -13.3% | -14.5% | ||
| Q4 24 | -35.6% | 11.2% | ||
| Q3 24 | 15.7% | -15.9% | ||
| Q2 24 | -34.3% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 2.4% | ||
| Q3 25 | 0.1% | 3.9% | ||
| Q2 25 | 0.2% | 12.9% | ||
| Q1 25 | 0.1% | 27.0% | ||
| Q4 24 | 0.3% | 18.3% | ||
| Q3 24 | 0.3% | 33.5% | ||
| Q2 24 | 0.1% | 31.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | 13.79× | — | ||
| Q1 25 | -1.33× | — | ||
| Q4 24 | -0.87× | 1.12× | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCH
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
